ConductScience.org, home

Paper977950

Activation of the alternative complement pathway by water-insoluble glucans of streptococcus mutans: the relation between their chemical structures and activating potencies.

Inal S and 4 others. J Immunol, 1976. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Activation of the alternative complement pathway by water-insoluble glucans of streptococcus mutans: the relation between their chemical structures and activating potencies. Papers, record 977950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/977950

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Activation of the alternative complement pathway by water-insoluble glucans of streptococcus mutans: the relation between their chemical structures and activating potencies.
PubMed
Journal
J Immunol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
0.63
iCite
Revised in PubMed
2013-11-21
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Inal SS
2Nagaki KK
3Ebisu SS
4Kato KK
5Kotani SS

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement System ProteinsMajor topic
Polysaccharides, BacterialMajor topic
StreptococcusMajor topic
Streptococcus mutansMajor topic
Aspergillus niger
Cell Wall
Complement C3
Complement C5
Complement Fixation Tests
Dose-Response Relationship, Immunologic
Humans
Solubility
Water

Source PubMed

Download CSV of topics

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
20028806Influence of mannan and glucan on complement activation and C3 binding by Candida albicans.Infect Immun2010https://conductscience.org/library/papers/20028806PubMed
8092994Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation.Biochem J1994https://conductscience.org/library/papers/8092994PubMed
8008701Plasma factor triggering alternative complement pathway activation by liposomes.Pharm Res1994https://conductscience.org/library/papers/8008701PubMed
7396479Extraction, distribution and biodegradation of bacterial lipopolysaccharides in estuarine sediments.Antonie Van Leeuwenhoek1980https://conductscience.org/library/papers/7396479PubMed
7095853Immunological activities of Capnocytophaga cellular components.Infect Immun1982https://conductscience.org/library/papers/7095853PubMed
7012020Chemical and biological properties of a peptidoglycan isolated from Treponema pallidum kazan.Infect Immun1981https://conductscience.org/library/papers/7012020PubMed
6409812Immunobiological activities of synthetic lipid A analogs and related compounds as compared with those of bacterial lipopolysaccharide, re-glycolipid, lipid A, and muramyl dipeptide.Infect Immun1983https://conductscience.org/library/papers/6409812PubMed
6388669Studies of four Japanese families with hereditary angioneurotic edema: simultaneous activation of plasma protease systems and exogenous triggering stimuli.Blut1984https://conductscience.org/library/papers/6388669PubMed
4089757Update on the immunomodulating activities of glucans.Springer Semin Immunopathol1985https://conductscience.org/library/papers/4089757PubMed
3980084Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs.Infect Immun1985https://conductscience.org/library/papers/3980084PubMed
721136Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity.Immunology1978https://conductscience.org/library/papers/721136PubMed
590998Insoluble polyanions as activators of both pathways of complement.Immunology1977https://conductscience.org/library/papers/590998PubMed
526039"Immune complexes" in every cutaneous vasculitis with "immune deposits"?Arch Dermatol Res1979https://conductscience.org/library/papers/526039PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
C3718PubTator's text mininghttps://conductscience.org/library/genes/718NCBI Gene
C5727PubTator's text mininghttps://conductscience.org/library/genes/727NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/977950

GET https://conductscience.org/api/papers/v1/977950/authors